Pascale Palassin
Montpellier, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Parkinsonism as a Potential Neurologic Immune-Mediated Adverse Event of Immune Checkpoint Inhibitors.
Journal: Neurology(R) neuroimmunology & neuroinflammation
Published: August 10, 2026
JAK Inhibitors and Memory Impairment: Disproportionality Analyses in the WHO Global Pharmacovigilance Database, VigiBase.
Journal: Fundamental & clinical pharmacology
Published: August 04, 2025
CFTR modulators-induced acne: Case series and analysis of pharmacovigilance databases.
Journal: Annales de dermatologie et de venereologie
Published: June 20, 2025
Ursodeoxycholic Acid Alone Is Effective and Safe to Treat Cholestatic Checkpoint Inhibitor-Induced Liver Injury.
Journal: Liver international : official journal of the International Association for the Study of the Liver
Published: December 30, 2024
Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM.
Journal: Alimentary pharmacology & therapeutics
Published: June 18, 2024
Auto-inflammatory reaction triggered by Nivolumab: A case of adult-onset Still's disease-like syndrome
Journal: Bulletin du cancer
Published: March 20, 2024
Cholangitis Induced by Immune Checkpoint Inhibitors: Analysis of Pharmacovigilance Data.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 13, 2023
Comparison of clinical safety between standard versus extended interval dosing of immune checkpoint inhibitors: a real-world retrospective cohort study.
Journal: ESMO open
Published: June 13, 2023
Hemophagocytic Lymphohistiocytosis Associated with Immunological Checkpoint Inhibitors: A Pharmacovigilance Study.
Journal: Journal of clinical medicine
Published: January 26, 2023
Clinical pattern of checkpoint inhibitor-induced liver injury in a multicentre cohort.
Journal: JHEP reports : innovation in hepatology
Published: January 10, 2023
Underreporting of Major Cardiac Adverse Events With Immune Checkpoint Inhibitors in Clinical Trials: Importance of Postmarketing Pharmacovigilance Surveys.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 01, 2022
Last Updated: 09/26/2026